Susquehanna International Group’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,351
| Closed | -$27.5K | – | 6881 |
|
|
2025
Q1 | $27.5K | Buy |
4,351
+2,282
| +110% | +$14.4K | ﹤0.01% | 6114 |
|
|
2024
Q4 | $21.3K | Buy |
2,069
+1,811
| +702% | +$18.7K | ﹤0.01% | 5990 |
|
|
2024
Q3 | $3.32K | Sell |
258
-445
| -63% | -$5.73K | ﹤0.01% | 5504 |
|
|
2024
Q2 | $9.73K | Sell |
703
-6,163
| -90% | -$85.3K | ﹤0.01% | 5477 |
|
|
2024
Q1 | $2.14M | Buy |
6,866
+1,678
| +32% | +$522K | ﹤0.01% | 1745 |
|
|
2023
Q4 | $1.36M | Buy |
5,188
+1,931
| +59% | +$506K | ﹤0.01% | 2424 |
|
|
2023
Q3 | $637K | Buy |
3,257
+3,019
| +1,268% | +$590K | ﹤0.01% | 3101 |
|
|
2023
Q2 | $48.8K | Buy |
+238
| New | +$48.8K | ﹤0.01% | 5214 |
|
|
2023
Q1 | – | Sell |
-272
| Closed | -$42.6K | – | 6411 |
|
|
2022
Q4 | $42.6K | Sell |
272
-159
| -37% | -$24.9K | ﹤0.01% | 5203 |
|
|
2022
Q3 | $108K | Buy |
+431
| New | +$108K | ﹤0.01% | 5228 |
|
|
2022
Q1 | – | Sell |
-224
| Closed | -$49K | – | 6206 |
|
|
2021
Q4 | $49K | Sell |
224
-94
| -30% | -$20.6K | ﹤0.01% | 5470 |
|
|
2021
Q3 | $145K | Sell |
318
-113
| -26% | -$51.5K | ﹤0.01% | 4857 |
|
|
2021
Q2 | $173K | Buy |
+431
| New | +$173K | ﹤0.01% | 4910 |
|